Analysts: UnitedHealth’s Warning Means Buy Now and 2 Other Research Notes To Read Now

UnitedHealth (NYSE:UNH): The company’s recent warning about its FY2014 outlook resulting from Medicare Advantage cuts pose a buying opportunity, according to Oppenheimer. The firm keeps a $66 price target and Outperform rating on the shares, citing that the concerns appear to be overblown.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

UNH

VeriFone (NYSE:PAY): VeriFone has fallen out of favor with Compass Point, which downgraded its shares from Buy to Neutral. The firm is more wary heading into the earnings report, as it believes there is potential for further revenue declines and potential goodwill impairment. It also lowered its price target from $25 to $20.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

PAY

Cypress Semiconductor (NASDAQ:CY): Needham believes that Cypress’s sell-off is an overreaction to the company’s weaker than expected Q2 outlook, but lowered its price target from $13 to $12. It also recommends buying shares at the current levels. 

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

cy

Investing Insights: Is Pfizer a Good Defensive Play?

More Articles About:    

More from The Cheat Sheet